1	19 Current psychosis or moderate to severe depression or use of anti-psychotic drugs MAOIs tricyclic antidepressants benzodiazepine or barbiturate treatment for disorders other than epilepsy and stimulants amphetamine derivatives within 28 days before the screening visit|benzodiazepine[117,131]||||||||||1402|1402|benzodiazepine
1	19 Current psychosis or moderate to severe depression or use of anti-psychotic drugs MAOIs tricyclic antidepressants benzodiazepine or barbiturate treatment for disorders other than epilepsy and stimulants amphetamine derivatives within 28 days before the screening visit|tricyclic antidepressants[91,116]|||||||||C0003290|928|928|tricyclic antidepressants
1	19 Current psychosis or moderate to severe depression or use of anti-psychotic drugs MAOIs tricyclic antidepressants benzodiazepine or barbiturate treatment for disorders other than epilepsy and stimulants amphetamine derivatives within 28 days before the screening visit|barbiturate[135,146]||||||||||1326|1326|barbiturate
1	19 Current psychosis or moderate to severe depression or use of anti-psychotic drugs MAOIs tricyclic antidepressants benzodiazepine or barbiturate treatment for disorders other than epilepsy and stimulants amphetamine derivatives within 28 days before the screening visit|amphetamine[206,217]|||||||28 days[237,244]||C0002658|725|725|amfetamine
1	19 Current psychosis or moderate to severe depression or use of anti-psychotic drugs MAOIs tricyclic antidepressants benzodiazepine or barbiturate treatment for disorders other than epilepsy and stimulants amphetamine derivatives within 28 days before the screening visit|stimulants[195,205]||||||||||||
